معرفی
Professor Chen Zhengming holds the Richard Peto Chair in Epidemiology at the University of Oxford's Nuffield Department of Population Health. He is also an Honorary Visiting Professor at institutions like Fudan University and Shanghai Institute of Biological Sciences. His research focuses on genetic epidemiology, clinical trials, and public health policy, with significant contributions to global health through large-scale studies like the China Kadoorie Biobank (CKB), a cohort of 512,000 adults.
Key achievements include landmark trials demonstrating aspirin's benefits in stroke and dual-antiplatelet therapy in acute MI, influencing international guidelines. His work on cholesterol, tobacco-attributed deaths in China, and genetic studies on alcohol and cardiovascular risk has shaped policy and clinical practices. He leads a team of over 100 researchers and has published over 475 papers, including highly cited works in Lancet, NEJM, and Nature Medicine.
- Awards: Bayer International Aspirin Award (1997), Wellcome Trust Advisory Board (2022), and numerous international recognitions.
- Leadership: PI and Director of China Kadoorie Biobank; contributor to global consortia like the International Hundred K+ Cohorts.
